TMAVA, a metabolite of intestinal microbes, is increased in plasma from patients with liver steatosis, inhibits -Butyrobetaine hydroxylase, and exacerbates fatty liver in mice
Estimated stability: ~3 months when stored as directed Other Components: Ethyl Alcohol, PEG400, Water Disclaimer: For laboratory research use only
Another randomized, double-blind, placebo-controlled trial split their trial group of 159 patients with mild Graves orbitopathy, into two groups
Documented side effects No published clinical trial has quantified how often GHK-Cu causes side effects in humans, at any dose or route
For years, mitochondria were thought of purely as the powerhouse of the cell, quietly converting nutrients into ATP